Search Results 10401-10410 of 15312 for CLL
-
Marla Broadfoot, Ph.D. March 26, 2026. Immunotherapy boosts chemotherapy in combating stage 3 colon cancer featured image. Cancer.
-
Lung cancer begins as a growth of cells in the lungs. Risk factors include smoking, secondhand smoke, exposure to certain toxins and family history. Symptoms.
-
Mayo Clinic has refined a preclinical model that lays the foundation for its first-ever larynx transplant. The model assesses the unique immunosuppressive needs ...
-
This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.
-
Knowledge of DNA repair mechanisms advances with new paper from Mayo Clinic scientists featured image · Mayo Clinic launches first-in-world mate-pair sequencing ...
-
The purpose of this study is to compare standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed acute myeloid ...
-
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
-
The purpose of this study is to determine the efficacy and safety of bel-sar compared to sham control for the treatment of primary indeterminate lesions and ...
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
Amir Lerman, M.D., a cardiovascular physician-scientist, mentor, research leader and active Mayo Clinic staff member, passed away Feb. 23 at age 69.